188 related articles for article (PubMed ID: 9122188)
41. Signal transduction pathways regulated by prolactin and Src result in different conformations of activated Stat5b.
Kabotyanski EB; Rosen JM
J Biol Chem; 2003 May; 278(19):17218-27. PubMed ID: 12621061
[TBL] [Abstract][Full Text] [Related]
42. Physical and functional interactions between Stat5 and the tyrosine-phosphorylated receptors for erythropoietin and interleukin-3.
Chin H; Nakamura N; Kamiyama R; Miyasaka N; Ihle JN; Miura O
Blood; 1996 Dec; 88(12):4415-25. PubMed ID: 8977232
[TBL] [Abstract][Full Text] [Related]
43. p300/CREB-binding protein enhances the prolactin-mediated transcriptional induction through direct interaction with the transactivation domain of Stat5, but does not participate in the Stat5-mediated suppression of the glucocorticoid response.
Pfitzner E; Jähne R; Wissler M; Stoecklin E; Groner B
Mol Endocrinol; 1998 Oct; 12(10):1582-93. PubMed ID: 9773981
[TBL] [Abstract][Full Text] [Related]
44. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
45. Role of signal transducer and activator of transcription 5 in nucleophosmin/ anaplastic lymphoma kinase-mediated malignant transformation of lymphoid cells.
Nieborowska-Skorska M; Slupianek A; Xue L; Zhang Q; Raghunath PN; Hoser G; Wasik MA; Morris SW; Skorski T
Cancer Res; 2001 Sep; 61(17):6517-23. PubMed ID: 11522649
[TBL] [Abstract][Full Text] [Related]
46. Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo.
Zvonic S; Story DJ; Stephens JM; Mynatt RL
Biochem Biophys Res Commun; 2003 Mar; 302(2):359-62. PubMed ID: 12604355
[TBL] [Abstract][Full Text] [Related]
47. Dominant negative variants of the SHP-2 tyrosine phosphatase inhibit prolactin activation of Jak2 (janus kinase 2) and induction of Stat5 (signal transducer and activator of transcription 5)-dependent transcription.
Berchtold S; Volarevic S; Moriggl R; Mercep M; Groner B
Mol Endocrinol; 1998 Apr; 12(4):556-67. PubMed ID: 9544991
[TBL] [Abstract][Full Text] [Related]
48. Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) alpha and PPARgamma.
Shipley JM; Waxman DJ
Mol Pharmacol; 2003 Aug; 64(2):355-64. PubMed ID: 12869640
[TBL] [Abstract][Full Text] [Related]
49. Role of Stat5 in type I interferon-signaling and transcriptional regulation.
Uddin S; Lekmine F; Sassano A; Rui H; Fish EN; Platanias LC
Biochem Biophys Res Commun; 2003 Aug; 308(2):325-30. PubMed ID: 12901872
[TBL] [Abstract][Full Text] [Related]
50. Grb-IR: a SH2-domain-containing protein that binds to the insulin receptor and inhibits its function.
Liu F; Roth RA
Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10287-91. PubMed ID: 7479769
[TBL] [Abstract][Full Text] [Related]
51. Constitutive activation of STAT5 by a point mutation in the SH2 domain.
Ariyoshi K; Nosaka T; Yamada K; Onishi M; Oka Y; Miyajima A; Kitamura T
J Biol Chem; 2000 Aug; 275(32):24407-13. PubMed ID: 10823841
[TBL] [Abstract][Full Text] [Related]
52. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
Sotiropoulos A; Moutoussamy S; Renaudie F; Clauss M; Kayser C; Gouilleux F; Kelly PA; Finidori J
Mol Endocrinol; 1996 Aug; 10(8):998-1009. PubMed ID: 8843416
[TBL] [Abstract][Full Text] [Related]
53. Cytokine receptor-independent, constitutively active variants of STAT5.
Berchtold S; Moriggl R; Gouilleux F; Silvennoinen O; Beisenherz C; Pfitzner E; Wissler M; Stöcklin E; Groner B
J Biol Chem; 1997 Nov; 272(48):30237-43. PubMed ID: 9374508
[TBL] [Abstract][Full Text] [Related]
54. Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways.
Ali S; Ali S
J Biol Chem; 1998 Mar; 273(13):7709-16. PubMed ID: 9516478
[TBL] [Abstract][Full Text] [Related]
55. Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl.
Carlesso N; Frank DA; Griffin JD
J Exp Med; 1996 Mar; 183(3):811-20. PubMed ID: 8642285
[TBL] [Abstract][Full Text] [Related]
56. Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase.
Najjar SM; Philippe N; Suzuki Y; Ignacio GA; Formisano P; Accili D; Taylor SI
Biochemistry; 1995 Jul; 34(29):9341-9. PubMed ID: 7626603
[TBL] [Abstract][Full Text] [Related]
57. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
Brelje TC; Svensson AM; Stout LE; Bhagroo NV; Sorenson RL
J Histochem Cytochem; 2002 Mar; 50(3):365-83. PubMed ID: 11850439
[TBL] [Abstract][Full Text] [Related]
58. A single amino acid in the DNA binding regions of STAT5A and STAT5B confers distinct DNA binding specificities.
Boucheron C; Dumon S; Santos SC; Moriggl R; Hennighausen L; Gisselbrecht S; Gouilleux F
J Biol Chem; 1998 Dec; 273(51):33936-41. PubMed ID: 9852045
[TBL] [Abstract][Full Text] [Related]
59. Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b.
Shipley JM; Waxman DJ
Toxicol Appl Pharmacol; 2004 Sep; 199(3):275-84. PubMed ID: 15364543
[TBL] [Abstract][Full Text] [Related]
60. Stat 5B, activated by insulin in a Jak-independent fashion, plays a role in glucokinase gene transcription.
Sawka-Verhelle D; Tartare-Deckert S; Decaux JF; Girard J; Van Obberghen E
Endocrinology; 2000 Jun; 141(6):1977-88. PubMed ID: 10830280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
